Understanding MMSE Score Declines in Alzheimer's and Depression
Author Information
Author(s): Sejunaite Karolina, Belal Yosra, Lanza Claudia, Riepe Matthias W.
Primary Institution: Ulm University, Ulm, Germany
Hypothesis
Does a decline in MMSE scores indicate the same cognitive deficits in Alzheimer's disease and depressive disorder?
Conclusion
Memory performance is the most important measure of disease severity in Alzheimer's disease, suggesting it should be prioritized in clinical assessments.
Supporting Evidence
- A decline in MMSE score from 30 to 27 indicates different cognitive impairments in Alzheimer's disease compared to depressive disorder.
- Memory recall is significantly more impaired in Alzheimer's disease than in depressive disorder.
- Changes in cognitive measures other than memory should prompt consideration of comorbidities.
Takeaway
This study shows that when people with Alzheimer's disease and depression lose points on a memory test, it means different things for each condition.
Methodology
The study analyzed data from a retrospective observational clinical cohort study focusing on MMSE scores in patients with verified Alzheimer's disease and depressive disorder.
Potential Biases
Potential bias due to the retrospective nature of the study and lack of informed consent.
Limitations
The study did not analyze comorbidities and drug use, and the group sizes were smaller when split by MMSE scores.
Participant Demographics
Patients included 167 with Alzheimer's disease and 69 with depressive disorder, with a mean age around 76-78 years.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website